GSK’s candidate Shingles Vaccine Containing Agenus’ QS-21 Stimulon® Demonstrates 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Yea

Go back to GSK’s candidate Shingles Vaccine Containing Agenus’ QS-21 Stimulon® Demonstrates 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Yea
AGENUS (NASDAQ: AGEN) Delayed: 3.07 +0.03 (0.99%)
Previous Close $3.04    52 Week High $7.49 
Open $2.99    52 Week Low $2.61 
Day High $3.18    P/E N/A 
Day Low $2.99    EPS $-1.10 
Volume 438,570       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 52.07 +1.33 (2.62%)
Previous Close $50.74    52 Week High $45.58 
Open $51.63    52 Week Low $37.82 
Day High $52.12    P/E N/A 
Day Low $51.51    EPS $0.00 
Volume 3,008,311